Table 1.
Summary of pCN for patients with and without overlapping oncogenic Drivers and Respective Statistics
| Including MET-related Overlapping Oncogenic Driver | Excluding MET-Related Overlapping Oncogenic Driver | MET-Related Overlapping Oncogenic Drivers Only | |||
|---|---|---|---|---|---|
|
| |||||
| With Overlapping Oncogenic Driver | Without Overlapping Oncogenic Driver | With Overlapping Oncogenic Driver | Without Overlapping Oncogenic Driver | ||
|
| |||||
| N | 43 | 146 | 20 | 146 | 23 |
| Median pCN | 2.5 | 2.8 | 2.5 | 2.8 | 2.6 |
|
| |||||
| Mean pCN | 2.9 | 3.8 | 2.9 | 3.8 | 2.8 |
|
| |||||
| pCN range | 2.1-6.7 | 2.1-52.9 | 2.2-6.7 | 2.1-52.9 | 2.1-4.5 |
|
| |||||
| Mann-Whitney U test P value | .033 | 0.116 | |||